On February 20, 2019 PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) Axis, reported two presentations at upcoming investor conferences. Daphne Zohar, co-founder and chief executive officer, will present at the SVB Leerink Global Healthcare Conference in New York on Friday, March 1, at 11:30 AM EST (Press release, PureTech Ventures, FEB 20, 2019, View Source [SID1234533513]). Additionally, Joep Muijrers, PhD, chief financial officer, will present at the Cowen and Company 39th Annual Health Care Conference in Boston on Tuesday, March 12, at 8:00 AM EST. Webcasts of both presentations will be available at View Source under the Reports and Presentations tab.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!